NL-OMON27467已完成不适用
Observational study;<br>Bevacizumab, Radiotherapy and Temozolomide Safety study in biopsied or resected primary GBM patients.
Departments of Neurosurgery, Radiation Oncology, Clinical Oncology and NeurologyAcademisch Medisch CentrumMeibergdreef 151105 AZ Amsterdam+31 20 56691110 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients with histologically proven GBM (biopsy or resection);
- •2. Can start 3-8 weeks post biopsy or surgery;
排除标准
- •1. Age <18 years;
- •2. Pregnancy;
研究者
相似试验
已完成
不适用
Bevacizumab in the Radiation Treatment of Recurrent Malignant GliomaBrain CancerRecurrent Malignant GliomasPrimary Brain TumorNCT00595322Memorial Sloan Kettering Cancer Center25
终止
不适用
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System TumorsRadiation NecrosisNCT01201850University of Colorado, Denver7
招募中
2 期
Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain InjuryBrain InjuriesNCT05303259Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University204
已完成
2 期
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB Cervical Cancer AJCC v6 and v7Stage IIA Cervical Cancer AJCC v7Stage IIB Cervical Cancer AJCC v6 and v7Stage III Cervical Cancer AJCC v6 and v7NCT00369122National Cancer Institute (NCI)60
Unknown
2 期
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal CancerRectal CancerNCT01818973Sun Yat-sen University45